87. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Samstag, 10. April 2021 (Posterwalk 1) 12:00-13:00

Postervorträge

Risikofaktoren und periphere Atherosklerose

Diskussionsleiter: I. Ahrens (Köln), D. G. Sedding (Halle (Saale))

(P1464) Association of Lipoprotein(a)-levels with intrinsic and on-clopidogrel platelet reactivity
    A. Kille, K. Franke, T. Nührenberg, C. M. Valina, F.-J. Neumann, W. Hochholzer (Bad Krozingen)
(P1465) Associations of patient disease-related knowledge and treatment goal attainment for LDL-C and HbA1c in very high-risk patients with cardiovascular disease and diabetes mellitus
    M. Brockmeyer, E. Wies, Y. Lin, A. Karathanos, C. Parco, A. Sokolowski, A. Hoss, J. Sommer, S. Grobosch, V. Schulze, S. Perings, N. Chernyak, M. Kelm, A. Icks, G. Wolff (Düsseldorf)
(P1466) Cutaneous Manifestations in Familial Hypercholesterolemia
    J. Katzmann, M. Lehmann, A. Tünnemann-Tarr, W. März, U. Laufs (Leipzig, Mannheim)
(P1467) Glycated haemoglobin A1c levels for the prediction of cardiovascular outcomes in the general population: Results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
    C. Sinning, N. Makarova, H. Völzke, R. Schnabel, N. Rübsamen, F. Ojeda-Echevarria, M. Dörr, S. B. Felix, W. Koenig, A. Peters, W. Rathmann, B. Schöttker, H. Brenner, G. Veronesi, G. Cesana, P. Brambilla, T. Palosaari, K. Kuulasmaa, I. Njølstad, E. B. Mathiesen, T. Wilsgaard, S. Blankenberg, S. Söderberg, M. Ferrario, B. Thorand, für die Studiengruppe: BiomarCaRE (Hamburg, Greifswald, München, Neuherberg, Düsseldorf, Heidelberg; Varese, Milano, IT; Helsinki, FI; Tromsø, NO; Umeå, SE)
(P1468) Acute Effects of Empagliflozin on Hemodynamic Parameters in Patients with Type 2 Diabetes
    K. Thiele, M. Rau, N. Marx, M. Lehrke, M. Böhm, J. Möllmann, N.-U. Hartmann, A. P. Keszei (Aachen, Homburg/Saar)
(P1469) Genetic absence of Tumor necrosis factor receptor-associated factor 5 (TRAF-5) aggravates diet-induced adipose tissue inflammation and its metabolic complications in mice.
    M. C. Gissler, N. Anto-Michel, X. Li, T. Marchini, T. Abogunloko, T. Mwinyella, A. Zirlik, C. Bode, F. Willecke, D. Wolf (Freiburg im Breisgau; Graz, AT)
(P1470) Association between BMPR2 mutations and iron metabolism in pulmonary arterial hypertension patients
    V. Theobald, E. Grünig, N. Benjamin, B. Egenlauf, H. Gall, G. Ardeschir, M. Halank, S. Harutyunova, M. Hoeper, D. Jonigk, M. Schneider, H.-J. Seyfarth, S. Richtmann, P. Xanthouli, M. Muckenthaler, C. Eichstaedt (Heidelberg, Gießen, Dresden, Hannover, Leipzig)
(P1471) Improved cardiac function and arterio-ventricular coupling in patients with peripheral artery disease following peripheral intervention
    G. Fuchs, D. Messiha, L. Halfmann, M. Steinmetz, T. Rassaf, C. Rammos (Essen, Düsseldorf)
(P1472) Intravascular lithotripsy in calcified, iliac, femoropopliteal and crural lesions: real-world single-center experience
    D. Kretzschmar, M. Thieme, C. Schulze, S. Möbius-Winkler (Jena, Sonneberg)
(P1473) Sex related differences in therapy and outcome of patients with intermittent claudication in a real-world cohort
    L. Makowski, J. Feld, J. Köppe, J. Illner, L. Kühnemund, A. Wiederhold, P. Dröge, C. Günster, J. Gerß, H. Reinecke, E. Freisinger (Münster, Berlin)